ERIS LIFESCIENCES
Back to Cashflow Statement
|
ERIS LIFESCIENCES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹1,065 Cr | ₹486 Cr | ₹292 Cr | ₹378 Cr | ₹375 Cr |
What is the latest Cash Flow from Operating Activities ratio of ERIS LIFESCIENCES ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹1,065 Cr |
| Mar2024 | ₹486 Cr |
| Mar2023 | ₹292 Cr |
| Mar2022 | ₹378 Cr |
| Mar2021 | ₹375 Cr |
How is Cash Flow from Operating Activities of ERIS LIFESCIENCES Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,065 Cr | 119.13 | |
| Mar2024 | ₹486 Cr | 66.59 | |
| Mar2023 | ₹292 Cr | -22.87 | |
| Mar2022 | ₹378 Cr | 0.77 | |
| Mar2021 | ₹375 Cr | - | |
Compare Cash Flow from Operating Activities of peers of ERIS LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ERIS LIFESCIENCES | ₹20,108.1 Cr | 1% | 6.1% | -16.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,507.0 Cr | 1.1% | 7.2% | 15.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹190,744.0 Cr | 2.4% | 4.2% | -1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹168,250.0 Cr | 1.9% | 8.3% | 45.6% | Stock Analytics | |
| CIPLA | ₹116,213.0 Cr | -1.8% | 3.2% | -4.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,980.0 Cr | -8.8% | -3.2% | -4.6% | Stock Analytics | |
ERIS LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ERIS LIFESCIENCES | 1% |
6.1% |
-16.3% |
| SENSEX | -1.4% |
4.4% |
-7.6% |
You may also like the below Video Courses